Antitrypsin deficiency is a primary cause of juvenile liver disease, and it arises from expression of the "Z" variant of the ␣-1 protease inhibitor (A1Pi). Whereas A1Pi is secreted from the liver, A1PiZ is retrotranslocated from the endoplasmic reticulum (ER) and degraded by the proteasome, an event that may offset liver damage. To better define the mechanism of A1PiZ degradation, a yeast expression system was developed previously, and a gene, ADD66, was identified that facilitates A1PiZ turnover. We report here that ADD66 encodes an ϳ30-kDa soluble, cytosolic protein and that the chymotrypsin-like activity of the proteasome is reduced in add66⌬ mutants. This reduction in activity may arise from the accumulation of 20S proteasome assembly intermediates or from qualitative differences in assembled proteasomes. Add66p also seems to be a proteasome substrate. Consistent with its role in ER-associated degradation (ERAD), synthetic interactions are observed between the genes encoding Add66p and Ire1p, a transducer of the unfolded protein response, and yeast deleted for both ADD66 and/or IRE1 accumulate polyubiquitinated proteins. These data identify Add66p as a proteasome assembly chaperone (PAC), and they provide the first link between PAC activity and ERAD.
INTRODUCTIONNewly synthesized secreted proteins must pass a stringent quality control checkpoint in the endoplasmic reticulum (ER), which ensures that only properly folded, assembled, and processed proteins transit the secretory pathway (Ellgaard and Helenius, 2003). Polypeptides that fail to pass this checkpoint may be targeted for ER-associated degradation (ERAD), a process in which aberrant proteins are selected and then delivered-or retrotranslocated-to the cytoplasm and degraded by the 26S proteasome (Fewell et al., 2001;Tsai et al., 2002;Kostova and Wolf, 2003;Meusser et al., 2005;Romisch, 2005;Sayeed and Ng, 2005;Nandi et al., 2006). The 26S proteasome is an ϳ2.5-MDa multisubunit complex that contains a central 20S proteolytic core particle and two 19S regulatory particles (Voges et al., 1999;Nandi et al., 2006). The 20S core harbors three distinct proteolytic activities-a chymotrypsin-like (CTL), a trypsin-like (TL), and a peptidylglutamyl-peptide hydrolyzing (PGPH) activitywhereas the 19S "cap" (also known as PA700) functions as a gatekeeper at the entrance of the core particle. In addition, the 19S particle contains polyubiquitin-binding subunits, enzymes required for polypeptide deubiquitination, and six AAA ATPases that are thought to unfold and feed polypeptides into the core Voges et al., 1999;Leggett et al., 2002;Verma et al., 2002;Guterman and Glickman, 2004;Soboleva and Baker, 2004).Some ERAD substrates in humans are mutated versions of wild-type proteins, and not surprisingly, their absence may lead to the onset of specific diseases Hannan, 2000, 2002;Coughlan and Brodsky, 2003). One substrate in which the connection between ERAD and lossof-function disease is very clear is the Z-variant of ␣-1-antitrypsin, also known as A1PiZ (or ␣-1 proteas...